The US FDA is investigating the safety risks of CAR-T cancer treatment
The US Food and Drug Administration said it is investigating cancer treatments developed by Gilead Sciences, Johnson & Johnson, Novartis and others because of the risk of hospitalisation and death due to a serious safety issue.
POPULAR POSTS
LIVE STREAM
